Lovisa Sandberg

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase

Lovisa Sandberg, H. Taavola, Yasunori Aoki et al. · Drug Safety · 2020 · 60 citations · Full text

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports

Rika Wakao, H. Taavola, Lovisa Sandberg et al. · Drug Safety · 2019 · 46 citations · Full text

<scp>vigiRank</scp> for statistical signal detection in pharmacovigilance: First results from prospective real‐world use

Ola Caster, Lovisa Sandberg, Tomas Bergvall et al. · Pharmacoepidemiology and Drug Safety · 2017 · 28 citations · Full text

Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre

Kristina Star, Lovisa Sandberg, Tomas Bergvall et al. · Pharmacoepidemiology and Drug Safety · 2019 · 26 citations · Full text

Longitudinal medical records as a complement to routine drug safety signal analysis

Kristina Star, Sarah Watson, Lovisa Sandberg et al. · Pharmacoepidemiology and Drug Safety · 2015 · 19 citations · Full text

Pharmacotherapy, Adverse Drug Reaction, Pre-clinical Pharmacology +23